Beruflich Dokumente
Kultur Dokumente
OBJECTIVES
Upon completion of this session, the learner will be able to:
1. 2. 3. 4. 5. 6. 7. List cancer statistics related to incidence, cases, and deaths. Define cancer. Explain theories of causation, grading, and staging of cancer. Discuss various treatment modalities available for cancer. State principles of cancer treatment. Examine common side effects, complications, and nursing management related to treatment modalities. Review basic solid tumors and hematological malignancies.
Glossary of Terminology
Neoplasm
Benign
Malignant
Metastasis
STATISTICS
Cancer
is the second leading cause of death in the United States affects one in three families
Cancer
STATISTICS
Incidence: #1 Skin Male Prostate Lung Colon/Rectum Female Breast Lung Colon/Rectum Colon/Rectum Colon/Rectum Death: Male: Lung Female: Lung
Prostate
Breast
CANCER
THEORIES OF CAUSATION
Environmental (tobacco, occupational, pesticides,
asbestos)
Genetics (BRCA)
Hormonal Imbalances Viral (HIV, H Pylori, HPV)
Stress
DEFINITIONS
1. Cancer is a disease of the cell 2. Large group of diseases characterized by: a. Abnormal cell structure (no differentiation) b. Uncontrolled growth (proliferation)
Cancer cells follow no rules and have the ability to stimulate the growth of a new blood supply
TNM STAGING
T= Tumor T0-T4
N = Node No-N3
M = Metastasis
SURGERY
Curative Prophylactic Diagnostic Staging
Palliative
Adjuvant or Supportive
Reconstructive/Rehabilitative
RADIATION
Highest energy rays that can kill any cell or tissue May be external source (brachytherapy) Curative Palliative 60% will receive XRT Divided into doses or fractions (Preserve normal cellular growth)
CHEMOTHERAPY
CHEMOTHERAPY
Chemotherapy
Cytotoxic drugs that destroy cancer cells or prevent cellular replication by interfering with DNA and RNA and vital cellular proteins
Goal is to reduce the number of cells to a small number that can be (theoretically) handled by the immune system
BIOTHERAPY
Treatment that alters the bodys biological response Uses bodys own immune system to treat cancer Alters the immune system with either stimulatory or suppressive effect Produce anti-tumor activities
HORMONAL THERAPY
used
against hormonally sensitive tumors like breast and prostate unfavorable growth environment
creates
GOALS
CURE
CONTROL PALLIATION
MYELOSUPPRESSION
NEUTROPENIA
THROMBOCYTOPENIA ANEMIA
NEUTROPENIA
Pathophysiology
Damage to stem cells in bone marrow with decreased ability to make these important cells Hematologic malignancies cause the malignant cells to crowd the bone marrow and therefore difficult to make normal amount of normal cells Solid tumors metastasize to bone marrow with a decreased normal cell production Radiation damages bone marrows ability to make cells
Neutropenia/Leukopenia
(Age, renal and liver function, nutrition, bone marrow, other medications, prior chemotherapy and/or radiation)
Manifestations include
Neutropenia/Leukopenia
Prevention:
No fresh fruits or vegetables, no pepper, live plants or potting soil No exposure to live vaccines or pet excreta Avoid others with colds Strict hand washing and personal hygiene
Neutropenia/Leukopenia
Management:
BC lines and peripheral, urine, sputum CXR and good physical assessment Antibiotics immediately (broad spectrum coverage) Administer neupogen or leukine Patient education (temperature at least 2 times daily) Vital signs at least every 4 hours or more Assess for chills, SOB, cough, pain
Thrombocytopenia
Management
Institute bleeding precautions <50,000/mm3 Decrease activity and no lifting or straining/Valsalva High fiber, increase fluids, stool softeners No razors, nail clippers, douching, tampons, water-soluble lubricants, no flossing, guiac/hemocult, pad counts Maintain SBP <140mm/Hg No IM injections, apply pressure to all sites, no NSAIDS, administer platelets per protocol Educate patients signs and symptoms
Anemia
Assess for
Anemia
Management:
Iron
Transfusion Epogen (Hct<30 % or Hbg <9g/dl) @ 40,000u weekly Patient education on signs and symptoms
Neupogen
Leukine
Neulasta Neumega
they are glycosylated proteins that function to regulate cell reproduction, cell maturation, and cell function of blood cells
GI Symptom Management
Symptom Management
Nausea/Vomiting
***As many as 60% patients experience nausea and vomiting
Patterns Anticipatory (starts and may last several hours to days)
medications, ICP, SIADH, stress Assess for weight loss, albumin, hydration
Nausea/Vomiting
Seratonin Inhibitors/Antagonists
receptors on vagus nerve and in the CTZ effectiveness may be enhanced by concurrent administration of decadron act by blocking seratonin from binding to receptors in GI tract (not indicated for anticipatory or delayed N&V)
Nausea/Vomiting
Phenothiazines
only mildly useful as single agents better in combination with other antimetics block dopamine receptors in CTZ works well for XRT, and morphine associated nausea
Nausea/Vomiting
Glucocorticosteroids effective with mild emetic drugs may block prostaglandin release from hypothalmus Dexamethasone (decadron) Methylprednisone (solumedrol) prednisone
Nausea/Vomiting
Most effective agent against Cisplatin Do not use with GI obstruction Blocks CTZ and promotes gastric emptying
Metoclopramide (reglan)
Nausea/Vomiting
Cannabinoids effective with some refractory cases Dronabinol (marinol) Butyrophonones Inapsine (droperidol) Haldol
Nausea/Vomiting
Antihistamines good with motion sickness blocks extrapyrammidal effects of other antimetics not effective as single agents
Nausea/Vomiting
Benzodiazepines amnesiac effect in drug combinations blocks short term memory
Nausea/Vomiting
Anticipatory N & V need to mediate the response of the centers in the cerebral cortex which result in anticipatory nausea and vomiting
Nausea/Vomiting
ACUTE N&V: mild potential drugs suggested to use phenothiazide =/- steroid or low dose reglan =/steroids moderate potential benefit from po/IV 5-HT3 antagonist =/- steroid or reglan =/- steroid
high potential benefit from po/IV 5-HT3 antagonist PLUS a steroid =/- a benzodiazepine
Nausea/Vomiting
Delayed N&V corticosteroids commonly used in combination with 5HT3 antagonist or reglan
Up to 80% develop mouth sores Assess and prevent NSS mouth rinses
50-100%
patients
SKIN REACTIONS
Hypersensitivity Hyper pigmentation Photo sensitivity Radiation recall Radiation enhancement Ulceration Palmar-Planter Erythrodysestheses (PPE)
THE UGLY
Cardiac Toxicity
Pulmonary
Urologic
Renal/Nephrotoxicity
Hepatotoxicity
Neurotoxicity
Ocular Toxicities
SOLID TUMORS
Neurological:
Brain Spinal Cord
SOLID TUMORS
SOLID TUMORS
LUNG
SOLID TUMORS
Esophageal Gastric Colorectal Pancreatic Hepatocellular
SOLID TUMORS
GU CANCERS
Kidney Bladder Prostate
SOLID TUMORS
GENITALCANCER
SKIN CANCER
LEUKEMIAS
ACUTE: AML ALL
LYMPHOMAS
Non-Hodgkins & Hodgkins
MULTIPLE MYELOMA
HEMTOLOGICAL MALIGNANCIES
IDIOPATHIC
HEMTOLOGICAL MALIGNANCIES
THROMBOTIC THROMBOCYTOPENIA
PURPURA (TTP)
HEMTOLOGICAL MALIGNANCIES
APLASTIC ANEMIA
REFERENCES
Fishman, M., & Orlowski, M.M. (Eds.). (1999). Cancer chemotherapyguidelines and recommendations for practice: ONS (2nd ed.). OncologyNursing Press Inc. Groenwald, S.L., Froygl, M.H., Goodman, M., & Yarbo, C.H. (Eds.). (2002). Cancer nursing: Principles and practice (5th ed.). Boston: Jones and Bartlett Publishing
Itano, J.K. & Taoka, K.N. (1998). Core curriculum for oncology nursing (3rd ed.). Philadelphia: W.B. Saunders.